Genus (CHIX:GNSL) Total Operating Expense: £597.5 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GNSL Genus PLC CHIX:GNSL
72 GF Score
Price £21.44
GF Value £20.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus Total Operating Expense?

Genus CHIX:GNSL +1.23% 72 Total Operating Expense is £597.5 Mil as of Dec. 2025. GuruFocus rates CHIX:GNSL with a GF Score™ of 72/100 and a GF Value™ of £20.63 (Fairly Valued). The stock has 5 warning signs investors should review.

Genus's Total Operating Expense for the six months ended in Dec. 2025 was £299.8 Mil. Genus's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was £597.5 Mil.


Genus Total Operating Expense Related Terms


Genus Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Genus's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus Total Operating Expense Chart

Genus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102.90 96.50 143.50 147.70 153.20

Genus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.30 325.50 323.90 297.70 299.80
CHIX:GNSL
72GF Score
Genus PLC CHIX:GNSL
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genus Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £597.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of £597.5 Mil mean?
Genus (CHIX:GNSL) has a Total Operating Expense of £597.5 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Genus and its competitors.
Is Genus' Total Operating Expense too high?
Genus' current Total Operating Expense is £597.5 Mil. Overall, Genus has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' Total Operating Expense compare to VRTX and REGN?
Genus' Total Operating Expense of £597.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Genus and its competitors. Genus's current Total Operating Expense is £597.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (CHIX:GNSL) is currently considered Fairly Valued. The stock's GF Value™ is £20.63, compared to a current price of £21.44 — trading 3.9% above its estimated fair value. The current Total Operating Expense is £597.5 Mil. Genus' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Genus (CHIX:GNSL), the current Total Operating Expense is £597.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (CHIX:GNSL) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £21.44 is trading 3.9% above its estimated GF Value™ of £20.63. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for CHIX:GNSL:

  • Total Operating Expense: £597.5 Mil
  • GF Value™: £20.63 vs. price of £21.44 (3.9% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the CHIX:GNSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
72GF Score

Get the complete analysis for CHIX:GNSL

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£21.44
Price
£20.63
GF Value